DE602005014382D1 - 2-pyrimidinyl-pyrazolopyridin-erbb-kinaseinhibitoren - Google Patents
2-pyrimidinyl-pyrazolopyridin-erbb-kinaseinhibitorenInfo
- Publication number
- DE602005014382D1 DE602005014382D1 DE602005014382T DE602005014382T DE602005014382D1 DE 602005014382 D1 DE602005014382 D1 DE 602005014382D1 DE 602005014382 T DE602005014382 T DE 602005014382T DE 602005014382 T DE602005014382 T DE 602005014382T DE 602005014382 D1 DE602005014382 D1 DE 602005014382D1
- Authority
- DE
- Germany
- Prior art keywords
- kinase inhibitors
- pyrimidinyl
- erbb kinase
- pyrazolopyridine
- pyrimidinyl pyrazolopyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63792804P | 2004-12-21 | 2004-12-21 | |
US70907905P | 2005-08-17 | 2005-08-17 | |
PCT/US2005/044166 WO2006068826A2 (en) | 2004-12-21 | 2005-12-06 | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005014382D1 true DE602005014382D1 (de) | 2009-06-18 |
Family
ID=36588699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005014382T Active DE602005014382D1 (de) | 2004-12-21 | 2005-12-06 | 2-pyrimidinyl-pyrazolopyridin-erbb-kinaseinhibitoren |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1828185B1 (de) |
JP (1) | JP5132319B2 (de) |
AT (1) | ATE430747T1 (de) |
DE (1) | DE602005014382D1 (de) |
ES (1) | ES2325035T3 (de) |
WO (1) | WO2006068826A2 (de) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7812022B2 (en) | 2004-12-21 | 2010-10-12 | Glaxosmithkline Llc | 2-pyrimidinyl pyrazolopyridine ErbB kinase inhibitors |
US7968538B2 (en) * | 2005-01-25 | 2011-06-28 | Galenea Corp. | Substituted arylamine compounds and methods of treatment |
CN101326182B (zh) * | 2005-12-05 | 2011-09-28 | 史密丝克莱恩比彻姆公司 | 2-嘧啶基吡唑并吡啶ErbB激酶抑制剂 |
WO2008003766A2 (en) * | 2006-07-06 | 2008-01-10 | Boehringer Ingelheim International Gmbh | 4-heter0cycl0alkylpyri(mi)dines, process for the preparation thereof and their use as medicaments |
WO2008129070A1 (en) * | 2007-04-24 | 2008-10-30 | Ingenium Pharmaceuticals Gmbh | Inhibitors of protein kinases |
US8067409B2 (en) | 2007-11-27 | 2011-11-29 | Abbott Laboratories | Protein kinase inhibitors |
AU2009214440B2 (en) | 2008-02-15 | 2014-09-25 | Rigel Pharmaceuticals, Inc. | Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases |
UA103319C2 (en) | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
US9273077B2 (en) | 2008-05-21 | 2016-03-01 | Ariad Pharmaceuticals, Inc. | Phosphorus derivatives as kinase inhibitors |
HUE035029T2 (en) | 2008-05-21 | 2018-03-28 | Ariad Pharma Inc | Kinase inhibitor phosphorus derivatives |
JP5490137B2 (ja) * | 2008-12-19 | 2014-05-14 | ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ | プロテインキナーゼ阻害薬としての二環式ピラゾール |
EP2435435B1 (de) * | 2009-05-27 | 2014-01-29 | AbbVie Inc. | Pyrimidinhemmer der kinaseaktivität |
JP2012528175A (ja) * | 2009-05-27 | 2012-11-12 | アボット・ラボラトリーズ | キナーゼ活性のピリミジン阻害剤 |
CN102725292A (zh) * | 2009-11-02 | 2012-10-10 | 雅培制药有限公司 | 作为用于多靶激酶抑制的新构建物的咪唑并吡啶化合物 |
UY33213A (es) * | 2010-02-18 | 2011-09-30 | Almirall Sa | Derivados de pirazol como inhibidores de jak |
EP2360158A1 (de) * | 2010-02-18 | 2011-08-24 | Almirall, S.A. | Pyrazolderivate als JAK-Inhibitoren |
AR080374A1 (es) | 2010-03-05 | 2012-04-04 | Sanofi Aventis | Procedimiento para la preparcion de 2-(ciclohexilmetil)-n-(2-((2s)-1-metilpirrolidin-2-il) etil)- 1,2,3,4-tetrahidroisoquinolin-7- sulfonamida |
EP2402336A1 (de) * | 2010-06-29 | 2012-01-04 | Basf Se | Pyrazolopyridin-Verbindungen |
EP2463289A1 (de) | 2010-11-26 | 2012-06-13 | Almirall, S.A. | Imidazo[1,2-b]Pyridazin-Derivate als AS JAK-Hemmer |
CN103501612B (zh) | 2011-05-04 | 2017-03-29 | 阿里亚德医药股份有限公司 | 抑制表皮生长因子受体导致的癌症中细胞增殖的化合物 |
SG10201910984XA (en) * | 2011-07-27 | 2020-01-30 | Astrazeneca Ab | 2 - (2, 4, 5 - substituted -anilino) pyrimidine derivatives as egfr modulators useful for treating cancer |
EP2554544A1 (de) | 2011-08-01 | 2013-02-06 | Almirall, S.A. | Pyridin-2(1H-)-on-Derivate als JAK-Inhibitoren |
AU2013204563B2 (en) | 2012-05-05 | 2016-05-19 | Takeda Pharmaceutical Company Limited | Compounds for inhibiting cell proliferation in EGFR-driven cancers |
DK2925757T3 (en) * | 2012-11-19 | 2018-01-15 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
US9611283B1 (en) | 2013-04-10 | 2017-04-04 | Ariad Pharmaceuticals, Inc. | Methods for inhibiting cell proliferation in ALK-driven cancers |
CN104829613B (zh) * | 2015-04-13 | 2020-06-09 | 赤峰蒙广生物科技有限公司 | 二芳基取代的吡唑并环类衍生物、其制备方法及其在医药领域的应用 |
US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
WO2020168197A1 (en) | 2019-02-15 | 2020-08-20 | Incyte Corporation | Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors |
US11472791B2 (en) | 2019-03-05 | 2022-10-18 | Incyte Corporation | Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors |
US11919904B2 (en) | 2019-03-29 | 2024-03-05 | Incyte Corporation | Sulfonylamide compounds as CDK2 inhibitors |
WO2020223558A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | Tricyclic amine compounds as cdk2 inhibitors |
WO2020223469A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer |
US11427567B2 (en) | 2019-08-14 | 2022-08-30 | Incyte Corporation | Imidazolyl pyrimidinylamine compounds as CDK2 inhibitors |
KR20220099970A (ko) | 2019-10-11 | 2022-07-14 | 인사이트 코포레이션 | Cdk2 억제제로서의 이환식 아민 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RS49779B (sr) * | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
-
2005
- 2005-12-06 AT AT05853157T patent/ATE430747T1/de not_active IP Right Cessation
- 2005-12-06 DE DE602005014382T patent/DE602005014382D1/de active Active
- 2005-12-06 EP EP05853157A patent/EP1828185B1/de active Active
- 2005-12-06 WO PCT/US2005/044166 patent/WO2006068826A2/en active Application Filing
- 2005-12-06 JP JP2007546747A patent/JP5132319B2/ja not_active Expired - Fee Related
- 2005-12-06 ES ES05853157T patent/ES2325035T3/es active Active
Also Published As
Publication number | Publication date |
---|---|
EP1828185B1 (de) | 2009-05-06 |
JP5132319B2 (ja) | 2013-01-30 |
WO2006068826A2 (en) | 2006-06-29 |
ATE430747T1 (de) | 2009-05-15 |
WO2006068826A3 (en) | 2006-10-05 |
JP2008524220A (ja) | 2008-07-10 |
EP1828185A2 (de) | 2007-09-05 |
ES2325035T3 (es) | 2009-08-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
WO2007067506A3 (en) | 2-pyrimidinyl pyrazolopyridine erbb kinase inhibitors | |
TW200610531A (en) | Phthalazine derivatives as PARP inhibitors | |
SE0301372D0 (sv) | Novel compounds | |
SG154432A1 (en) | Quinazolinedione derivatives as parp inhibitors | |
EA200800546A1 (ru) | Бензимидазолтиофеновые соединения в качестве ингибиторов polo-подобных киназ (plk) | |
SG154434A1 (en) | Quinazolinone derivatives as parp inhibitors | |
SE0301700D0 (sv) | Novel compounds | |
SE0101675D0 (sv) | Novel composition | |
ATE479687T1 (de) | Kinaseinhibitoren | |
EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
NO20071915L (no) | Diaminotriazolforbindelser nyttige som proteinkinaseinhibitorer | |
TW200740815A (en) | P38 MAP kinase inhibitors and methods for using the same | |
AU2003228770A8 (en) | Substituted pyrazolopyrimidines | |
EA200801291A1 (ru) | Карбониламинопирролопиразолы в качестве эффективных ингибиторов киназ | |
MY148634A (en) | Pyridazinone derivatives | |
TW200624426A (en) | BACE inhibitors | |
UA86591C2 (ru) | Пирролодигидроизохинолины как ингибиторы pde10, фармацевтическая композиция на их основе | |
UA85505C2 (en) | Kinase inhibitors | |
WO2007120333A3 (en) | Tetracyclic kinase inhibitors | |
WO2007056625A3 (en) | Thienopyridine b-raf kinase inhibitors | |
TW200736227A (en) | New compounds III | |
BRPI0615141A2 (pt) | inibidores pentacìclicos de quinase | |
ATE507218T1 (de) | Benzodiazepin-derivate als rock-kinasen hemmer | |
ATE274515T1 (de) | Pyrazolopyridinderivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |